{
    "2020-11-28": [
        [
            {
                "time": "",
                "original_text": "CDE前首席科学家、恒瑞、AZ、上药、微芯思辨研发内涵！中国医药创新到底是研大还是发大？如何平衡？谁将有潜力成为万亿市值药企？",
                "features": {
                    "keywords": [
                        "CDE",
                        "首席科学家",
                        "恒瑞",
                        "AZ",
                        "上药",
                        "微芯",
                        "医药创新",
                        "万亿市值"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "未来十年，医药行业投资机会在这！",
                "features": {
                    "keywords": [
                        "未来十年",
                        "医药行业",
                        "投资机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复星医药联席总裁陈玉卿：四个维度提升竞争力应对疫情挑战",
                "features": {
                    "keywords": [
                        "复星医药",
                        "陈玉卿",
                        "竞争力",
                        "疫情挑战"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}